Nektar Therapeutics | NKTR - Bienes





Bienes Cambio Fecha
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
ALKERMES USD 4.39B 135.05M 2026-06
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Amgen USD 95.64B 3.14B 2026-06
Baxter International USD 19.79B 55M 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Cara Therapeutics USD 25.82M 6.26M 2026-03
Cipla INR 424.96B 23.32B 2026-03
Dr.Reddys Laboratories INR 575.31B 5.93B 2026-06
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Exelixis USD 2.49B 99.36M 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Incyte USD 7.87B 533.53M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
Karyopharm Therapeutics USD 131.42M 23M 2026-03
MacroGenics USD 345.41M 127.54M 2026-06
Merck USD 129.8B 1.12B 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Takeda JPY 15.66T 210.16B 2026-06
Teva Pharmaceutical Industries USD 39.86B 183M 2026-06
Xencor USD 724.96M 11.89M 2026-06